Oramed Pharmaceuticals Inc. (ORMP) is a publicly traded Healthcare sector company. As of August 3, 2026, ORMP trades at $4.39 with a market cap of $166.57M and a P/E ratio of 2.81. ORMP moved +7.49% today. Year to date, ORMP is +54.04%; over the trailing twelve months it is +107.08%. Its 52-week range spans $1.82 to $5.19. Rallies surfaces ORMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ORMP news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.39 |
| Market Cap | $166.57M |
| P/E Ratio | 2.81 |
| EPS | $1.53 |
| Dividend Yield | 0.25% |
| 52-Week High | $5.19 |
| 52-Week Low | $1.82 |
| Volume | 259.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.00M |
| Net Income | $64.02M |
| Gross Margin | 0.65% |
ORMP analyst coverage data. Average price target: $0.00.